FDA Sent Warning Letter To Teva Pharmaceuticals Industries. The U.S. Food and Drug Administration (FDA) has sent a warning letter to Teva Pharmaceutical Industries Ltd on October 14, 2016. The warning letter is associated with an FDA Current Good Manufacturing Practices (CGMP) inspection of Teva's manufacturing facility. The FDA … [Read more...]
Teva Pharmaceuticals Warning Letter from FDA
Skincare Company gets FDA Warning Letter
Skincare Company Selling Unapproved Drugs. A warning letter was issued by the U.S. Food and Drug Administration (FDA) to a skincare company for promoting and selling unapproved new drugs. Whether at the District Office level or at Headquarters, the FDA will take steps against products promoted with unproven claims about a new product … [Read more...]
Unsafe Lime Crime Lipstick Ingredients Prompt FDA Warning Letter
Unsafe Lipstick Ingredients On Lime Crime's Lipstick. After learning about unsafe ingredients listed on the label of Lime Crime's Velvetines Liquid Matte Lipstick, the Food and Drug Administration (FDA) sent the company a warning letter directing it to correct the violations. The letter, dated July 29, warns Lime Crime that the … [Read more...]
L’Oreal Warned by FDA for Improper Marketing
FDA Warning Letter To L’Oreal Marketing. The U.S. Food and Drug Administration (FDA) has issued a February 12 warning letter to L'Oreal for the improper marketing of its Rosaliac AR Intense and Mela-D Pigment Control. According to Regulatory Affairs Professionals Society (RAPS), the agency said these products are being marketed as … [Read more...]
FDA Warning Letter Issued over Visipaque Web Site
FDA Warning Letter For Visipaque. GE Healhcare is in trouble with the U.S. Food & Drug Administration (FDA) over a Web site for its imaging drug, Visipaque. The agency issued GE a warning letter on January 7, saying the Visipaque Web site is misleading, and omits information about the drug's risks. Visipaque is used with … [Read more...]
FDA Warning Letter On German Plant
Warning Letter On Bayer German Plant. Following an inspection in March that caused the U.S. Food and Drug Administration (FDA) concern regarding Bayer AG’s ability to test and monitor quality, a warning was issued to the pharmaceutical giant. Reuters wrote that the issue concerned testing at Bayer’s Bergkamen, Germany facility, … [Read more...]
Genzyme Hit With FDA Warning Letter
Genzyme Received FDA Warning Letter. Biotech giant, Genzyme Corporation, has received a warning letter over what federal regulators are describing as “significant objectionable conditions” at its Boston manufacturing plant, reports the Boston Business Journal. The conditions were so problematic that the regulators are threatening … [Read more...]
